+482.3%
AXTI vs GSK
+97.4%
+384.9%
-92.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -12.3% | -0.1% | -12.1% | -12.2% |
| 7D | -26.9% | -5.3% | -21.6% | -25.9% |
| 30D | -48.4% | -3.7% | -44.8% | -48.1% |
| 3M | -58.2% | -7.3% | -50.9% | -57.6% |
| 6M | -70.8% | -4.2% | -66.5% | -71.1% |
| YTD | +87.0% | +0.9% | +86.1% | +81.0% |
| 1Y | +223.5% | +7.3% | +216.2% | +205.5% |
| 3Y | +1,391.2% | +52.7% | +1,338.5% | +1,086.3% |
| 5Y | +247.0% | +40.1% | +206.9% | +178.9% |
| All | +482.3% | +97.4% | +384.9% | +265.0% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling